Managers / Q4 2021 · view latest →
Roumell Asset Management, LLC
CIK 0001331693 · 2 WISCONSIN CIR, SUITE 700, CHEVY CHASE, MD, 20815 · 301-656-8500
Summary
Roumell Asset Management, LLC reported $75M in U.S.-listed holdings across 21 positions for Q4 2021.
Its largest position, GSIT, represents 12.1% of the portfolio.
Compared with Q3 2021, the fund opened 6 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 69.4% · $52M
- Other · 21.4% · $16M
- ADR · 9.3% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MGNIMAGNITE INC | NEW | +240.0K | 240.0K | +$4M | $4M |
| CMTLCOMTECH TELECOMMUNICATIONS C | NEW | +101.6K | 101.6K | +$2M | $2M |
| AMYRIS INC | NEW | +430.0K | 430.0K | +$2M | $2M |
| TTITETRA TECHNOLOGIES INC DEL | NEW | +704.3K | 704.3K | +$2M | $2M |
| ETONETON PHARMACEUTICALS INC | NEW | +449.4K | 449.4K | +$2M | $2M |
| KVHIKVH INDS INC | NEW | +76.3K | 76.3K | +$701,000 | $701,000 |
| EROS STX GLOBAL CORPORATION | SOLD OUT | −1.15M | 0 | −$1M | $0 |
| CLMBWAYSIDE TECHNOLOGY GROUP INC | SOLD OUT | −16.8K | 0 | −$453,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GSITGSI TECHNOLOGY INChistory → | COM | 12.07% | $9M | 1.96M |
| 2 | QUANTUM CORP | COM NEW | 11.51% | $9M | 1.56M |
| 3 | COLLPLANT BIOTECHNOLOGIES LT | SHS NEW | 10.81% | $8M | 495.7K |
| 4 | ENZBENZO BIOCHEM INChistory → | COM | 10.43% | $8M | 2.44M |
| 5 | ALLOT LTD | SHS | 9.72% | $7M | 614.0K |
| 6 | OPRAOPERA LTDhistory → | SPONSORED ADS | 7.48% | $6M | 794.4K |
| 7 | MGNIMAGNITE INChistory → | COM | 5.60% | $4M | 240.0K |
| 8 | COMSCORE INC | COM | 5.55% | $4M | 1.25M |
| 9 | CMTLCOMTECH TELECOMMUNICATIONS Chistory → | COM NEW | 3.21% | $2M | 101.6K |
| 10 | QUMU CORP | COM | 3.10% | $2M | 1.10M |
| 11 | AMYRIS INC | COM NEW | 3.10% | $2M | 430.0K |
| 12 | TTITETRA TECHNOLOGIES INC DELhistory → | COM | 2.67% | $2M | 704.3K |
| 13 | ETONETON PHARMACEUTICALS INChistory → | COM | 2.57% | $2M | 449.4K |
| 14 | BCDABIOCARDIA INChistory → | COM | 2.43% | $2M | 938.4K |
| 15 | EHTHEHEALTH INChistory → | COM | 2.08% | $2M | 61.2K |
| 16 | NODKNI HLDGS INChistory → | COM | 2.07% | $2M | 82.1K |
| 17 | SPARK NETWORKS SE | SPONSORED ADR | 1.79% | $1M | 426.4K |
| 18 | ARDSARIDIS PHARMACEUTICALS INChistory → | COM | 1.39% | $1M | 446.6K |
| 19 | KVHIKVH INDS INC | COM | 0.93% | $701,000 | 76.3K |
| 20 | STREAMLINE HEALTH SOLUTIONS | COM | 0.83% | $625,000 | 425.0K |
| 21 | RICEBRAN TECHNOLOGIES | COM NEW | 0.66% | $493,000 | 1.41M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2024 | $53M | 16 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $53M | 17 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $47M | 15 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $50M | 19 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $51M | 22 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $44M | 20 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $40M | 21 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $46M | 21 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $51M | 21 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $62M | 19 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $75M | 21 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $75M | 17 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $86M | 18 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $69M | 14 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $64M | 16 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $50M | 14 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $41M | 20 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $37M | 22 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $44M | 21 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $42M | 14 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $42M | 18 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $41M | 20 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $48M | 22 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.